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We applied a direct competitive immunoassay for measuring corticosterone and glucocorticoid metabolites 28 
in feces (FGMs) as a non-invasive tool for monitoring the stress response of African Penguins (Spheniscus 29 
demersus) held in captivity in a zoological facility. The developed assay,  validated in-house, proved to be 30 
rapid (the test could be completed in 90 minutes), sensitive (LOD for corticosterone 0.2 µg l-1, dynamic 31 
range 0.75-75 µg l-1) and broad-selective, as it cross-reacted with the major corticosteroids, thus allowing 32 
the detection of excreted FGMs resulting from a biological stressor. Matrix interference, due to 33 
components of faecal samples, was overcome by diluting sample extracts (1+4 or 1+9, depending on 34 
sample features). 35 
The assay enabled us to investigate the response to stress in five animals- three adult males and two adult 36 
females- over a period of 30 hours, and to identify the peak of FGM production as being 7-10 hours after 37 
the stressful event.  38 
 39 
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 41 
INTRODUCTION  42 
 43 
Animals held in captivity are subject to a variety of physical, social, dietary, and ecological limitations that 44 
affect their welfare and behavior.1,2 In recent years, several zoos and aquaria have intensified efforts to 45 
develop approaches and tools for assessing the well-being of captive animals, due to increasing public 46 
concern about animal welfare and ethical issues.3 The monitoring of animal welfare has been regulated by 47 
national and international provisions aimed at assuring biological and conservation requirements of 48 
individual species (e.g. Italian Legislative Decree 73,4 Council Directive 99/22/EC 5). In addition, several zoo 49 
associations operate at national and international levels in promoting excellence in animal care and 50 
welfare, and in maintaining a high standard of animal husbandry, e.g. UIZA (Unione Italiana Giardini 51 
Zoologici e Acquari),6 EAZA (European Association of Zoos and Aquaria),7 and WAZA (World Association of 52 
Zoos and Aquariums)8.  53 
A feasible way to monitor the welfare of animals held in captivity is represented by the evaluation of their 54 
response to stress caused by major constraints imposed by living in zoos. Exposure to stress usually results 55 
in an increased secretion of glucocorticoid hormones (GCs) from the adrenal cortex, and GCs are therefore 56 
commonly used as stress markers in human and vertebrate animals.9 The predominant avian GC is 57 
corticosterone (B), a C-21 hormone produced by the adrenal glands, involved in diverse regulatory 58 
mechanisms, including: immune reactions, protein synthesis and degradation, and metabolic reactions. The 59 
corticosterone plasmatic level is considered a reliable marker of stress levels in birds.9 Nevertheless, 60 
measuring corticosterone and related GCs in the plasma requires handling the animals for blood collection, 61 
which could elicit, in itself, a substantial rise in GC concentrations in the blood due to the stress caused by 62 
the restraint and taking blood.9 blood collection, maybe? 63 
An accepted alternative method for the evaluation of adrenocortical activity is the measurement of GC 64 
metabolites excreted in feces.10 Although GCs are not actually present in faeces as they are metabolized in 65 
the liver, their metabolic products are excreted into the gut via the bile. Faecal glucocorticoid metabolite 66 
(FGM) levels have been demonstrated to reflect plasmatic GC concentrations, although as an integrated 67 
measure over the time, and after a variable time delay compared to the plasmatic GC response to the 68 
stressful event.10,11 A major benefit of measuring FGMs is represented by the fact that faeces collection is a 69 
non-invasive practice, thus which allows allowing extensive sampling campaigns,  sample collection from 70 
small animals as well, and prevention of bias due to the sampling itself. Faeces can be easily collected, 71 
because there is no need to capture or handle the animals; therefore, repeated samplings from the same 72 
individual are possible without affecting the animal’s behavior.11 However, as metabolic pathways involved 73 
in GC degradation are numerous,12 and are influenced by several factors (including, but not limited to: 74 
species, gender, age, reproductive status, season, etc.), predicting the nature and the chemical structure of 75 
targets is almost unachievable. For the same reason, developing specific antibodies for the excreted 76 
metabolites of each species, in order to set dedicated immunoassays, is often impractical.13,14 Nevertheless, 77 
it has been argued that knowing the chemical identity of faecal GC metabolites in each species and for each 78 
condition is unnecessary.15  79 
The most widely accepted method to assess the stress response in animals by FGM measurement is a 80 
practical approach, based on the development of immunoassays that exploit so-called broad-selective 81 
antibodies (namely polyclonal antisera able to bind a group of related substances rather than a defined 82 
compound), and the demonstration of the capability of these assays to reflect adrenocortical activity by a 83 
physiological and/or biological validation.11 An increase of the response of the assay An increased response 84 
of the assay (expressed as an increase of FGM concentrations), following an appropriate stimulus, such as 85 
adrenocorticotropic hormone (ACTH) challenge or a recognized biological stressor, is assumed to 86 
demonstrate the capability of the assay to reflect changes in the activity of the hypothalamic–pituitary–87 
adrenal axes11,12 and thus to ascertain stress. The physiological and/or biological validation legitimizes the 88 
application of the assay for a certain species, and for those individuals and stressful conditions for which it 89 
has been tested.11,16 90 
The pre-requisite for developing a useful immunoassay is, therefore, the availability of antibodies able to 91 
bind the wider variety of GCs (i.e. having a broad selectivity). However, sensitivity is also crucial, mainly 92 
when FGMs have to be detected in minute quantities of faeces, such as those belonging to small avian 93 
species.14,17 FGM assays have been validated for a multitude of species, including several birds.9,17-19 Most of 94 
these studies tended to employ commercially-available radioimmunoassays or enzyme immunoassays 95 
primarily developed to measure cortisol or corticosterone, which usually only cross-reacted with a few 96 
other GCs (Table 1), not unexpectedly, as they were designed to selectively measure the target compound.  97 
Specially developed immunoassays have also been described, based on antibodies aimed at measuring a 98 
specific faecal GC metabolite (e.g. tetrahydrocorticosterone20) or designed to be group-specific (e.g. 11,17-99 
dioxoandrostanes11). Despite their selectivity profiles, all these immunoassays were shown to be able to 100 
measure an increase in FGMs that were artificially stimulated in physiological validation experiments. In 101 
addition, they have occasionally been applied for non-invasive investigation of the stress response induced 102 
by a specific constraint9,21,22. However, the conclusions drawn about the effect of a supposed stressful event 103 
on animals also depended on the responsiveness of the employed assay, or rather, the capability to detect 104 
the increased adrenocortical activity. A higher assay sensitivity (i.e. lower detection limits) would, of course, 105 
be desirable.  106 
Therefore, the aim of this work was to establish a sensitive and rapid enzymatic immunoassay in the direct 107 
competitive format that exploits a broad-selective antibody towards GCs. Assay optimization was 108 
conducted to identify experimental conditions aimed at maximizing sensitivity, and the developed assay 109 
was subjected to in-house analytical validation. The assay was used to measure FGMs from African 110 
Penguins (Spheniscus demersus) held in captivity in a biopark (ZOOM Torino, Italy), to and test its suitability 111 
for non-invasive monitoring of stress levels in these animals.  112 
The African Penguin is a marine bird endemic of  to South Africa and Namibia. The current conservation 113 
status of this species is “Endangered”, and WHO/WHAT? is indicated in the Red List of Threatened Species 114 
of the IUCN (International Union for Conservation of Nature) because the wild population has dramatically 115 
decreased in recent years to less than 75-80,000 mature individuals.23 Therefore, the African Penguin faces 116 
a great risk of extinction, and ex-situ conservation programs are becoming increasingly crucial. The African 117 
Penguin is a monogamous species with a complex behavioural repertoire,24 and is exhibited in large groups 118 
in zoos and aquaria all over the world. To improve the health and general well-being of African Penguins 119 
held in captivity, the identification of stressful conditions is required, in order to develop mitigating 120 
strategies. To successfully achieve conservation of endangered species, it is important that captive facilities 121 
focus their efforts on welfare and health, which [riferito a chi?] involves minimizing and reducing stressful 122 
stimuli facing animals in captive environments.25 Measuring glucocorticoids as an indicator of adrenal 123 
activity can help conservation biologists and animal managers understand the causes of poor welfare.26-29  124 
Matrix interference due to the variability of the faeces collected from five adult African Penguins (three 125 
males, and two females) over 30 hours was studied and surmounted through appropriate sample dilution. 126 
Immunoreactive FGM concentrations, measured by the developed assay, were also compared to those 127 
obtained by means of a reference enzyme immunoassay, previously developed and validated for a different 128 
species of penguin, the Adélie Penguin (Pygoscelis adeliae).30 129 
 130 
MATERIALS AND METHODS 131 
 132 
Materials 133 
Steroids (S, Table 1) were purchased from Steraloids (Newport, RI, USA), except for cortisol (F), which was 134 
obtained from Sigma-Aldrich (St. Louis, MO, USA). Bovine serum albumin (BSA), N,N’-135 
diisopropylcarbodiimide (DIC), N-hydroxysuccinimide (NHS), and 3,3’5,5’-tetramethylbenzidine liquid 136 
substrate (TMB) were also purchased from Sigma- Aldrich. Horse-radish peroxidase (HRP) was from Roche 137 
Diagnostics (Milan, Italy). Dimethylformamide (DMF), methanol, Tris(hydroxymethyl)aminomethane (TRIS) 138 
and all other chemicals and microtiter plates were obtained from VWR International (Milan, Italy). Rabbit 139 
polyclonal anti-3-(O-carboxymethyl)oxime-BSA antibodies were kindly supplied by G. Bolelli (Servizio di 140 
Fisiopatologia della Riproduzione, Policlinico S. Orsola, Bologna, Italy). 141 
The hapten used for enzyme labelling was cortisol-3-(O-carboxymethyl)oxime (F-3-cmo, Figure 1) and was 142 
synthesized as previously reported.31 F-3-cmo was then conjugated with HRP by the carbodiimide ester 143 
method.32 The obtained F-HRP conjugate was stored at 4°C, with the addition of 33% (v/v) of glycerol. The 144 
diluted working solution was prepared daily in TRIS buffer (20 Mm, pH 8.5, with 0.3M NaCl, 1% BSA, w/v, 145 
0.1% Tween 20, v/v). 146 
Steroid stock solutions were prepared by dissolving the powders in absolute ethanol and stored at -20°C. 147 
Standard solutions were prepared by daily diluting the stock solutions with methanol:water (35:65, v/v). 148 
 149 
Competitive Enzyme-Immunoassay (EIA) 150 
The immunoreactive solid phase was obtained by coating wells with 150 µl of the antiserum directed 151 
towards cortisol diluted 1:10,000 (v/v) with carbonate/bicarbonate buffer (50 mM, pH 9.6), followed by 152 
overnight incubation at 4°C. Uncoated well surfaces were blocked with 300 µl PBS supplemented with 0.5% 153 
of BSA for 1 hour at room temperature. Wells were then washed using a 0.05% Tween 20 solution.    154 
Calibration curves were constructed by adding 150 µl of F-HRP (1.5 mg L-1) to 50 µl of B diluted in aqueous 155 
methanol (35%, v/v) at concentrations ranging from 0 to 50 μg L-1. The mixture was incubated for 1 hour in 156 
immunoreactive wells, followed by washing, and colour development was then obtained by a 30 min 157 
incubation with TMB (200 µl per well). A volume of 50 µl of sulphuric acid (2M) was used as a stop solution, 158 
and absorbance was recorded at 450 nm. Unknown sample concentrations were measured by replacing the 159 
B standard solution with sample extracts diluted 1+1 with water as well as further dilutions of 1+4 or 1+9 160 
with aqueous methanol (35%, v/v). All standards and samples were measured in duplicate. 161 
Unknown FGM concentrations were determined by interpolation on the calibration curve, where the signal 162 
was plotted against the log of analyte concentration. For each experiment, a calibration curve was 163 
determined by nonlinear regression analysis of the data from the standards, using the four-parameter 164 
logistic equation.  165 
Relative cross-reactivity  (CR) was evaluated by carrying out standard curves of the investigated compounds 166 
(S) in the same experimental conditions as B, except for the concentration interval, which was in the range 167 
of 0-5000 μg L-1, and was calculated as follows: 168 
CR% = (IC50 B / IC50 S)*100 169 
where IC50 is the S concentration that causes 50% inhibition of the maximum observed signal. 170 
 171 
Samples and sample preparation 172 
A total of 28 faecal samples from three adult males and two adult females were collected. The colony was 173 
observed from a distance (>5 m), to avoid disturbing the animals, by a researcher standing motionless 174 
outside the exhibit. After a defecation event, the researcher entered into the exhibit and gathered the 175 
expelled faeces. As urinal and faecal excretion are combined in birds, we only collected the faecal portion 176 
from droppings, which was distinguishable by color.33 Faecal samples were collected into cryovials and 177 
stored immediately after collection at -20°C. 178 
Fortified samples were prepared by adding 2.5, 10, and 40 µg l-1 of B to three sample extracts, which had 179 
previously been tested as containing low levels of FGMs. 180 
FGM extraction was carried out as reported in the literature32 with the following modifications. Briefly, 181 
penguin faeces (which were contaminated with sand of the exhibit) were transferred to a 15 ml tube and 182 
extracted with 5 ml of methanol: water (70:30, v/v), by shaking on a rotary shaker for 30 min.  183 
After centrifugation for 5 min at 3000 x g to remove sand and particulate matter, 3 ml of the clear 184 
supernatant was transferred to a weighted tube, and the amount of the extracted sample was obtained as 185 
the difference between the total weight of the extract and the weight of the extraction solvent. 186 
Sample extracts were immediately stored at -20°C until required for analysis. 187 
 188 
RESULTS AND DISCUSSION 189 
 190 
Competitive Enzyme-Immunoassay analysis 191 
The polyclonal antiserum used to develop the assay was developed by stimulating an immune-response 192 
using an F conjugate. Nevertheless, cross-reactivity towards B was preliminary demonstrated to be 100% 193 
(Table 2); therefore this antiserum was deemed to be suitable for measuring GCs in general, and thus 194 
exploited to set the immunoassay.    195 
Checkerboard assays using various combinations of antibody and enzyme tracer concentrations were 196 
carried out to select appropriate F-HRP and antibody dilutions for the direct competitive assay. A dilution of 197 
1:10,000 (v/v) of antiserum, and a concentration of 1.5 mg L-1 of F-HRP were selected as being the most 198 
suitable based on the lowest IC50 value . B standards were diluted in aqueous methanol, as FGM extraction 199 
from faecal samples typically involves a high percentage of this solvent, according to the literature.11 The 200 
assay proved to be robust for methanol contents lower than 40%, whereas sensitivity decreased for higher 201 
solvent percentages. Dilution of B standards in TRIS buffer also negatively affected assay sensitivity and 202 
precision. Therefore, the ideal diluent for B standards was established to be methanol: water 35:65 (v/v).    203 
Figure 2 shows a typical inhibition curve obtained under optimized conditions. The IC50 value of the assay 204 
was 4.5 µg l-1. The limit of detection (LOD) was calculated at 90% inhibition of the maximum signal (Amax), 205 
and the dynamic range as the interval between 20 and 80% of Amax
34, and were estimated to be 0.2 µg l-1 206 
and 0.75-75 µg l-1, respectively. 207 
 208 
Selectivity of the assay 209 
According to the literature, tetrahydrocorticosterone (THB) is thought to be the main B metabolite;33 210 
however, this point is still debated, and several other possible metabolic products, characterized by very 211 
different chemical structures, have also been shown to be excreted in faecal samples of birds.12,15 Möstl et 212 
al.12 suggested at least seven possible metabolic pathways starting from B and resulting in the production 213 
of: 3-hydroxycorticoids, 11-oxocorticoids, 21-deoxycorticoids, 21-acid corticoids, 17-oxoandrostanes, and 6-214 
hydroxycorticoids. However, faecal metabolites of GCs in birds have not been positively identified, and no 215 
data are available on this subject in the literature. Most authors used competitive immunoassays (RIAs, 216 
Radio Immuno Assays or EIAs, Enzyme Immuno Assays), developed for measuring corticosterone or 217 
tetrahydrocorticosterone, as tools to assess FGM levels9,17,30, on the basis of a demonstration that the assay 218 
is capable of detecting an increase in FGMs, when artificially induced by an appropriate biochemical or 219 
biological stimulus. An increased immune-response of the assay is interpreted as a consequence of the 220 
increased FGM concentration, regardless of the identification of the chemical compound responsible for 221 
the increase.15 222 
Although responsiveness to induced stress of validated immunoassays for measuring FGMs is 223 
controversially related to cross-reactivity of the assay itself (i.e. the capability of detecting several different 224 
GCs), as is evident from Table 1, achieving broad-selectivity should be a major requirement for the 225 
analytical method to be applied for detecting FGMs. Therefore, the selectivity of a polyclonal antiserum, 226 
obtained by immunizing with a cortisol derivative modified in position 3 (Figure 1), was tested in response 227 
to a large number of steroid structures, which varied according to the substituents in position 3, 11, 6, and 228 
17, and according to the presence of insaturations at position 1-2 and 4-5, consistent with the hypothetical 229 
metabolic modifications which corticosterone can undergo. Relative cross-reactivities compared to B are 230 
shown in Table 2. Most steroids were recognized by the antiserum, at levels between 7 and 38%; among 231 
these, surprisingly, testosterone demonstrated a high cross-reactivity (30%) despite substantial 232 
modification of the substituent at position 17 compared to B and F. Oxidation of the 11-hydroxyl to form 233 
11-oxosteroids determined a sharp decrease in binding, as manifested by the relatively low cross-reactivity 234 
of cortisone compared to cortisol, and prednisone compared to prednisolone; on the contrary, the 235 
substitution of the 11-hydroxyl with hydrogen did not seem to negatively influence the binding (as evident 236 
by comparing P and 11-hydroxyl-P). The addition of a substituent at position 6 slightly affected the 237 
recognition (CR of metil-prednisolone and prednisolone were 26% and 38%, respectively).  238 
Otherwise, THB and THF showed absolutely no cross-reactivity. The lack of recognition of these compounds 239 
was mainly attributed to the hydroxyl substituent at position 3, whereas the saturated ring partially 240 
contributed to decrease cross-reactivity, as demonstrated by comparing CR% for the couple 241 
adrenosterone/androstanedione, differing in the insaturation of the A ring, which determined a limited CR%  242 
decrease (from 1% to 0.2%). Furthermore, androstenediol and androstan-3,17-diol, both having a hydroxyl 243 
at position 3, were not recognized, independently from the saturation state of the A ring. The applied 244 
extraction procedure could not exclude the presence of conjugates glucocorticoid metabolites, i.e. 245 
glucoronides at position 3. However, the conjugation of the hydroxyl substituent could contribute to 246 
reverse the decreasing of recognition.  247 
 248 
Penguin faeces analysis: analytical validation of the EIA 249 
 250 
Collection of faecal samples from African Penguins held in the exhibit of a park creates two main concerns, 251 
namely the limited amount of the sample available, and the presence of exogenous materials belonging to 252 
the exhibit, such as sand and pebbles. To address the first issue, the developed assay should be as sensitive 253 
as possible, and matrix interference should be counteracted without excessive sample dilution. To take into 254 
account the presence of spurious materials, quantitation of faeces was obtained by weighing a fixed 255 
volume of sample extracts, after centrifuging,, to remove undesired components, rather than weighing the 256 
samples themselves. To relate the quantity of measured FGMs to the sample amount, the contribution due 257 
to solvent weight was subtracted from the extract weight. The obtained sample weight was, in fact, the 258 
weight of the soluble or extractable portion of the sample. 259 
The extraction protocol was taken from the literature30 and applied without further optimization. Since 260 
samples were extracted with methanol/water 70/30, a 1+1 dilution with water was carried out to match 261 
the organic solvent content of samples with that of the B standards, and to preserve the sensitivity of the 262 
assay.. 263 
Furthermore, we observed that collected samples were very variable, not only in terms of the recovered 264 
amounts of faeces, but also in terms of the aspect of the extracts. Some extracts were intensely coloured 265 
(from pale yellow to dark green); some were transparent, while others were turbid, independently from 266 
regardless of the colour. The variable appearance of extracts was thought to be connected to faeces 267 
composition, and could depend on individual biological variability, individual circumstances at the time of 268 
collection, time elapsed from feeding, urea content, etc. Therefore, matrix interference on the assay was 269 
evaluated by carrying out recovery experiments on four representative samples: a turbid white (TW), a 270 
turbid orange (TO), a limpid light green (LG), and a limpid dark green sample (DG). Extracts were fortified at 271 
three levels with B (2, 10, and 50 μg l-1) and non-fortified and fortified samples were analysed using the 272 
developed EIA. All samples were strongly overestimated, as testified by recovery rates that were two to 273 
ten-fold greater than the expected values (data not shown). The same samples were also tested after being 274 
diluted with water or with methanol/water 35/65 as follows: 1+0, 1+1, and 1+4. In addition, two buffered 275 
solutions (TRIS buffer at pH 8 and 9) were evaluated as the F-HRP diluent. The pH of the buffering solution 276 
and the methanol content did not significantly affect the results obtained on faecal samples (data not 277 
shown); nevertheless, dilution factors were demonstrated to strongly influence FGM estimation, mostly for 278 
samples that displayed green coloured extracts (Figure 3). The TW sample showed very low levels of FGMs, 279 
which resulted as undetectable at higher dilution factors, and were related to the scarce faecal material 280 
present in the sample, as confirmed by calculated weight (5 mg). Turbidity, likely associated to urea content, 281 
seemed to have a lesser effect on the reliability of results, compared to colour. Green coloured samples 282 
were more prone to matrix interference than yellow-orange samples. 283 
To limit the matrix effect, and to establish a unique sample treatment, which possibly did not depend on 284 
the characteristics of the sample, an overall 1+9 dilution of faecal sample extracts was chosen, with the 285 
following diluents: 1+1 with water to reduce the organic solvent content and match conditions of the 286 
greatest sensitivity of the assay, followed by a further 1+4 dilution with methanol/water 35/65 (total 287 
sample extract dilution: 1:10). Nonetheless, very dark extracts were also analysed in a dilution of 1:20 (1+1 288 
with water and a further 1+9 with methanol/water), and FGM concentrations were calculated from the 289 
mean result of the two dilutions, when agreeing, otherwise from the value given by the higher dilution 290 
factor. 291 
The accuracy of the optimized EIA method was investigated by means of recovery experiments on three 292 
faecal sample extracts, which were previously assessed to contain low levels of FGMs (< 500 ng/g), and 293 
were fortified at three B levels: 2.5 (low), 10 (medium), and 40 μg l-1 (high). Within and between-assay 294 
precision was established by testing three faecal samples, which were shown to contain three 295 
concentration levels of FGMs (low, medium and high), in eight replicates from the same day, and on four 296 
different days, respectively (Table 4). Accuracy was between 83 and 116% (Table 3); within-assay precision 297 
was measured to be in the range of 7-8% (n=8); and between-assay precision was measured to be in the 298 
range of 5-16% (n=4). The figure of merits of the optimized assay demonstrated that the developed EIA is 299 
accurate and precise enough to allow FGM determinations in penguin faecal samples, regardless of sample 300 
composition. 301 
 302 
Biological validation of the EIA to assess adrenocortical response to stress 303 
To demonstrate the usefulness of the developed EIAas a non-invasive tool for detecting adrenocortical 304 
response to stress in African penguins, a biological validation was carried out. Faecal samples from three 305 
adult males and two adult females were collected after a well-known cause of stress, namely the capture 306 
and immobilization of animals.35,36 Sample collection started immediately after this stressful event, and 307 
continued until about 30 hours following the first collection, except at night. Sample frequency and 308 
numerosity depended on the individual, and ranged from three samples, from the animal named “G”, to 309 
seven samples from the animal known as “S”. The FGM content of each sample was measured by the 310 
developed v. The same samples were also analysed by the method validated by the group of Möstl and co-311 
workers30 for measuring FGMs in the faeces of Adélie Penguins (Pygoscelis adeliae) and Wilson's storm 312 
petrels (Oceanites oceanicus),20 as a reference method. FGMs measured by both analytical methods are 313 
shown in Table 5, together with the time elapsed from the stressful event, and the amount of the sample 314 
available for analysis. As is evident, for some samples, a reasonable amount of faeces could be collected, 315 
whilst in other cases the available amount was lower or absent; FGMs were therefore only measured in the 316 
samples for which at least 20 mg of faeces were available (as recommended17). 317 
Despite individual variability, results from all five animals qualitatively agreed in suggesting a peak of FGM 318 
production between 7 and 10 hours after the stressful circumstance. This observation is in good agreement 319 
with results previously reported for other birds. For example, Nagakawa et al. reported a profile of FGM 320 
excretion after ACTH administration which showed a peak after 6-18 hours in Adélie Penguins;30 Denhard et 321 
al. observed a significant increase in FGM levels at 5.5-8 hours after ACTH administration to chickens 322 
(Gallus domesticus).13  323 
In addition, the qualitative behaviour is in good agreement with results obtained through the reference EIA. 324 
Nevertheless, from a quantitative point of view, the developed EIA yielded higher levels of FGMs for all 325 
samples. The reference EIA, which used an antibody developed towards tetrahydrocortisone, generally 326 
gave lower FGM concentrations, and undetectable levels of FGMs in 12 out of the 22 samples analysed. The 327 
discrepancy between the two assays could be attributed to the different cross-reactivity profiles of the 328 
antibodies employed. The antibody used in the reference assay was decidedly more selective, as it only 329 
cross-reacted with 11-hydroxyandrosterone, tetrahydrocortisol, and cortol, while all other tested steroids 330 
(Table 1) showed cross-reactivity values lower than 1%. Since FGMs are a group of unknown compounds 331 
that are structurally variable at different positions, as they could belong to several metabolic pathways, the 332 
broader the selectivity of the assay, the higher the probability of detecting a larger number of compounds 333 





 We developed An enzyme immunoassay to detect glucocorticoid metabolites was developed, based on a 339 
broad-selective antibody. The assay was shown to be accurate, precise and decidedly more rapid than 340 
previously reported radio and enzyme immunoassays intended for measuring FGMs. Thus, the time needed 341 
to complete the analysis was 90 minutes, rather than overnight incubations, as required by existing 342 
immunoassays. The assay was applied to determine FGM levels from African penguins held in captivity, and 343 
demonstrated a reliable assessment of FGM increase solicited by an artificially induced biological stressor 344 
with high sensitivity. Indeed, ACTH infusion, which is the most commonly employed strategy to validate 345 
assays for FGMs, is a more efficient means to provoke the physiological increase of adrenocortical activity, 346 
and integrates the biological stress (capture, handling, injection) with the biochemical stimulus. However, 347 
as ACTH challenge is a potent stressor, the capacity of a proposed assay to detect the physiological 348 
response to stressful events could be overestimated by using this kind of inducement, thus limiting the 349 
reliability of conclusions drawn where less intense environmental, biological, or behavioural causes of 350 
stress are being investigated. The enzyme immunoassay developed in this study allowed the detection of 351 
an adrenocortical response to a biological stress (animal capture) in African penguins and demonstrated 352 
that the maximum physiological response (increase of FGMs) was reached after 7-10 h from the stressor. 353 
Therefore, this assay can be suggested as a reliable tool to evaluate the effect of potential stressful 354 
circumstances that these animals may undergo in captivity, such as, for example: visitor flow, excessive 355 
noise, and inappropriate weather. By identifying stressful stimuli, efforts can be made to reduce their effect 356 
and prevent their occurrence, in order to improve the general welfare of captive animals and increase 357 
breeding success. Nowadays, stress is one of the major issues facing zoological institutions around the 358 
world, and identifying and reducing sources of stress should therefore be a key factor for conservation 359 
programs of threatened species.25 360 
We propose the use of the African Penguin as a model species, and the application of the same 361 
methodology to evaluate the well-being of other endangered species kept in captivity. Groups of African 362 
Penguins are housed in zoos and aquaria worldwide; these colonies are formed by a high number of birds, 363 
enabling analysis of differences in age, gender and individuality. Finally, the ability to monitor 364 
adrenocortical activity in a non-invasive manner in African Penguins, and in general in endangered species 365 
held in captivity, is of major value in welfare management strategies, as prolonged periods of elevated GC 366 
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